total EBV reactivation   univariate
N = 116 18 (16.4%)  
Sex M 71 13 (18.3%) p=0.180
F 45 5 (11.1%)  
median age (range)   49,8 (17,6-70,6) 48,5(17,6-68,5)   p=0.445
Stemcell source cordblood 1 0 (0.0%) p=1.000
peripheral blood 106 17 (16.0%)  
bonemarrow 9 1 (11.1%)  
Donor Related 35 1 (2.9%) p=0.015
Unrelated 81 17 (21.0%)  
HLA mismatch   20 6 (30.0%) p=0.561
Conditioning NMA 106 15 (14.2%) p=0.359
  MA 10 3 (30.0%)  
ATG   87 18 (20.7%) p=0.004
EBV serology (R/D) +/+ 94 18 (19.1%) p=0.429
aGVHD   64 12 (18.8%) p=1.000
Abbreviations: HLA:Human Leukocyte Antigen; NMA:Non Myeloablative; MA:Myeloablative; ATG:Anti-Thymocyte Globulin; EBV: Epstein-Barr Virus; R/D:Recipient/Donor.
Comparison between reactivation and no reactivation group: Fisher’s Exact test.
Table 1A: Patient characteristics prospective study.